ArticleMolecules (Basel, Switzerland)2021

Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model.

Ricardo G Alvim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.